San Diego, CA -- (SBWIRE) -- 03/26/2019 -- The Shareholders Foundation announces that a deadline is coming up on April 1, 2019 in the lawsuit filed for investors of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) over alleged securities laws violations by Lexicon Pharmaceuticals, Inc.

Investors who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) have certain options and there are strict and short deadlines running. Deadline: April 1, 2019. NASDAQ: LXRX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) common shares that the Defendants made false and/or misleading statements and/or failed to disclose that the data from Lexicon's Phase 3 clinical trials assessing the safety and efficacy of Sotagliflozin in treating type 1 diabetes were not as positive as Lexicon represented, that the health risks posed by Sotagliflozin were severe enough to threaten its FDA approval prospects, and that as a result, Lexicon's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.